72 phenotypes from 3 alleles in 3 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Arv1em1(IMPC)J/Arv1em1(IMPC)J C57BL/6NJ-Arv1em1(IMPC)J/Mmjax	abnormal auditory brainstem response	J:211773
	decreased bone mineral density	J:211773
	decreased heart rate	J:211773
	hyperactivity	J:211773
	increased grip strength	J:211773
	increased thigmotaxis	J:211773
	prolonged RR interval	J:211773
Arv1tm1.2Geno/Arv1+ involves: C57BL/6 * C57BL/6J	increased circulating cholesterol level	J:263695
	increased circulating HDL cholesterol level	J:263695
Arv1tm1.2Geno/Arv1tm1.2Geno involves: C57BL/6 * C57BL/6J	abnormal bile salt homeostasis	J:263695
	abnormal enzyme/coenzyme level	J:263695
	abnormal feces composition	J:263695
	abnormal intestine physiology	J:263695
	abnormal liver physiology	J:263695
	abnormal maternal nurturing	J:263695
	decreased body fat mass	J:263695
	decreased brown adipose tissue amount	J:263695
	decreased circulating cholesterol level	J:263695
	decreased circulating HDL cholesterol level	J:263695
	decreased circulating lactate dehydrogenase level	J:263695
	decreased circulating leptin level	J:263695
	decreased circulating triglyceride level	J:263695
	decreased epididymal fat pad weight	J:263695
	decreased fasting circulating glucose level	J:263695
	decreased inguinal fat pad weight	J:263695
	decreased lean body mass	J:263695
	decreased liver cholesterol level	J:263695
	decreased liver free fatty acids level	J:263695
	decreased liver triglyceride level	J:263695
	decreased mesenteric fat pad weight	J:263695
	decreased retroperitoneal fat pad weight	J:263695
	decreased survivor rate	J:263695
	decreased susceptibility to diet-induced hepatic steatosis	J:263695
	decreased susceptibility to diet-induced obesity	J:263695
	decreased unsaturated fatty acids level	J:263695
	normal growth/size/body region phenotype	J:263695
	normal homeostasis/metabolism phenotype	J:263695
	impaired coordination	J:263695
	improved glucose tolerance	J:263695
	increased basal metabolism	J:263695
	increased bile salt level	J:263695
	increased blood urea nitrogen level	J:263695
	increased carbon dioxide production	J:263695
	increased circulating adiponectin level	J:263695
	increased circulating alkaline phosphatase level	J:263695
	increased circulating ghrelin level	J:263695
	increased energy expenditure	J:263695
	increased food intake	J:263695
	increased insulin sensitivity	J:263695
	increased locomotor activity	J:263695
	increased oxygen consumption	J:263695
	increased saturated fatty acids level	J:263695
	increased unsaturated fatty acids level	J:263695
	premature death	J:263695
	normal reproductive system phenotype	J:263695
	seizures	J:263695
Arv1tm1.2Radr/Arv1tm1.2Radr involves: 129S1/Sv * 129X1/SvJ * BALB/cJ	abnormal circulating lipid level	J:241193
	abnormal lipid metabolism	J:241193
	normal adipose tissue phenotype	J:241193
	normal behavior/neurological phenotype	J:241193
	decreased body fat mass	J:241193
	decreased circulating cholesterol level	J:241193
	decreased circulating HDL cholesterol level	J:241193
	decreased circulating leptin level	J:241193
	decreased fasting circulating glucose level	J:241193
	decreased lean body mass	J:241193
	decreased percent body fat/body weight	J:241193
	decreased respiratory quotient	J:241193
	decreased subcutaneous adipose tissue amount	J:241193
	decreased survivor rate	J:241193
	decreased white adipose tissue amount	J:241193
	decreased white fat cell size	J:241193
	female infertility	J:241193
	normal growth/size/body region phenotype	J:241193
	normal homeostasis/metabolism phenotype	J:241193
	hyperactivity	J:241193
	hypoglycemia	J:241193
	improved glucose tolerance	J:241193
	increased basal metabolism	J:241193
	increased carbon dioxide production	J:241193
	increased circulating adiponectin level	J:241193
	increased fatty acid oxidation	J:241193
	increased food intake	J:241193
	increased oxygen consumption	J:241193
	normal liver/biliary system phenotype	J:241193
	moribund	J:241193
	poor circulation	J:241193
	premature death	J:241193
	slow postnatal weight gain	J:241193